Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Galapagos NV    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Galapagos NV
Galapagos NV specializes in the research and development of drugs based on novel targets discovered and validated in human primary cells. Net sales break down by activity as follows:

- discovery and development of drugs (98.8%);

- other (1.2%).

Net sales are distributed geographically as follows: Europe (5.8%) and North America (94.2%).

Number of employees : 1 003 people.
Sales per Business
20182019Delta
EUR (in Million)%EUR (in Million)%
Research and Development278.6796.5%834.9098.8% +199.61%
Fee-for-Services10.173.5%10.081.2% -0.85%
Sales per region
2019
EUR (in Million)%
North America795.6194.2%
Europe49.025.8%
Asia Pacific0.3620%
Belgium--
France--
Croatia--
Managers
NameAgeSinceTitle
Onno van de Stolpe591999Chief Executive Officer & Executive Director
Raj Parekh582004Chairman
Bart Filius502017Chief Operating & Financial Officer
Piet Wigerinck, Dr.542012Chief Scientific Officer
Walid Abi-Saab, Dr.-2017Chief Medical Officer
Howard Mitchell Rowe, Dr.492010Independent Non-Executive Director
Katrine S. Bosley502013Independent Non-Executive Director
Mary Kerr, Dr.582016Independent Non-Executive Director
Peter Guenter582019Independent Director
Linda Slanec Higgins, Dr.562019Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 65,340,842 48,633,365 74.4% 0 0.0% 74.4%
Shareholders
NameEquities%
Gilead Sciences, Inc. 16,707,477 25.6%
Van Herk Investments BV 5,428,172 8.31%
Wellington Management Co. LLP 2,752,374 4.21%
Capital Research & Management Co. (World Investors) 2,086,815 3.19%
The Vanguard Group, Inc. 1,600,907 2.45%
Schroder Investment Management Ltd. 1,135,983 1.74%
Capital Research & Management Co. (Global Investors) 1,087,308 1.66%
Invesco Advisers, Inc. 993,066 1.52%
Norges Bank Investment Management 977,987 1.50%
T. Rowe Price International Ltd. 777,779 1.19%
Markets and indexes
-
- Compartiment A
- AEX / BEL 20, Euronext 100, Next Biotech, PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  GLPG:BB
- Reuters Code :  GLPG.BR
- Datastream Code :  
Company contact information
Galapagos NV
Generaal De Wittelaan L11 A3
BE-2800 Mechelen, Antwerpen


Phone : +32 15 34 29 00
Fax : +32 15 34 29 01
web site : http://www.glpg.com
Sector Biotechnology & Medical Research - NEC